Autoimmune hepatitis in Iranian children

Area of Science:

• Pediatric Gastroenterology
• Hepatology
• Autoimmune Diseases

Background:

• Autoimmune hepatitis (AIH) is a chronic liver disease of unknown etiology.
• Pediatric AIH presents unique challenges in diagnosis and management.
• Understanding the specific characteristics of AIH in different populations is crucial.

Purpose of the Study:

• To characterize the clinical and para-clinical features of autoimmune hepatitis in Iranian children.
• To investigate autoantibody patterns and treatment responses in this cohort.
• To provide insights into the management of pediatric AIH in Iran.

Main Methods:

• Retrospective analysis of clinical, serological, and histological data from 60 children diagnosed with AIH.
• Classification of patients into Type I and Type II AIH based on autoantibody profiles.
• Evaluation of clinical presentation, liver histology, and treatment outcomes.

Main Results:

• Common clinical findings included jaundice (67%), hepatomegaly (50%), and ascites (30%).
• Type I AIH was diagnosed in 40 children and Type II in 14.
• Liver histology showed comparable features between types, with significant initial cirrhosis rates (63% vs 34%).

Conclusions:

• The study outlines the presentation and clinical course of pediatric AIH in Iran.
• Corticosteroids and/or azathioprine demonstrated efficacy in achieving clinical, biochemical, and histological remission.
• This highlights the effectiveness of immunosuppressive therapy in managing pediatric AIH.